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In vitro models of human small intestine play a critical role in predicting oral 
drug absorption efficiency as well as understanding intestinal epithelia functionality. 
Conventional 2D in vitro models fail to represent small intestinal villi which are 
important 3D features for the small intestinal microenvironment. Without these 
features, in vitro models of the small intestine lack physiological relevance. By using 
microfabrication techniques, we created a plastic template with accurate dimensions 
and densities of human small intestinal villi. Based on this template, we fabricated 
collagen villous scaffolds utilizing a sacrificial hydrogel technique. By integrating 
collagen villous scaffolds into a custom designed insert kit, we developed the first 3D 
in vitro model of the human small intestine. Epithelial cells cultured on this 3D model 
presented unique cell differentiation morphology similar to human small intestine 
epithelia. Drug permeability tests conducted on this 3D model provided more accurate 
results for drugs absorbed through the paracellular pathway when compared to 
conventional 2D models. In addition, alternative biomaterials were tested for their 
potential in making 3D villous scaffolds.  This work suggests that the 3D in vitro 
model of the human small intestine is an effective tool for predicting drug 
permeability as well as investigating the small intestinal microenvironment. 
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PREFACE 
This dissertation was written based on the “papers option”, which means that the 
dissertation is composed of three research papers (which were either submitted or 
published during my Ph.D. study), one additional chapter and the final conclusion. 
The first chapter is a review paper about current in vitro small intestinal models with 
focuses on cellular physiology, extracellular topography and applications. The second 
chapter describes a novel method for fabricating 3D human small intestine villous 
scaffolds by combining laser fabrication and sacrificial molding technique. The third 
chapter describes how we developed the first 3D human small intestine in vitro model, 
which not only presented unique cellular differentiation morphology but also obtained 
a better permeability correlation to human intestines for paracellular pathway 
transported drugs. The fourth chapter introduces an alternative material which was 
tested for its potential for making villous scaffolds. In the final conclusion, I gave my 
personal insights and ideas for future directions of this project. We started this project 
without much precedent in the area of making synthetic villi. There are still many 
challenging problems that need to be solved and I hope this dissertation is a helpful 
resource for future research.  
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Ithaca, New York 
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CHAPTER ONE: 
SYNTHETIC SMALL INTESTINES FOR STUDYING INTESTINAL 
FUNCTION AND HOST-MICROBIAL INTERACTIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yu J a, Costello CM a, March JC *a
 
 (2012) Synthetic Small Intestines for Studying 
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ABSTRACT 
In vitro small intestinal models not only play a critical role for understanding small 
intestine functionality, predicting oral drug absorption efficiency and investigating cell 
differentiation mechanisms but are also becoming more important for illustrating 
complicated interactions between intestinal epithelial cells and commensal bacteria. In 
this review, in vitro small intestinal models are discussed with respect to cellular 
physiology and excellular topography. The roles of in vitro small intestinal models in 
investigating GI host-microbial interactions are discussed. 
 
INTRODUCTION 
Creating in vitro artificial small intestines that realistically mimic in vivo systems is 
one of the most exciting and promising areas of biotechnology [1, 5, 70], with 
potential to aid in the study of many under-researched gut disorders including Crohn’s 
disease [16], irritable bowel syndrome [46], short-bowel syndrome [48] and 
gastroenteritis [47]. Typically intestinal function and disease processes are assessed in 
vivo using live animal models [57], however multiple studies have shown that these 
models often do not correlate well with human systems [50], and are expensive and 
time consuming as well. Additionally, animal models do not allow for real-time visual 
documentation of cellular growth and survival, and they present limitations for control 
and manipulation of specific intestinal processes. In contrast, synthetic in vitro 
intestinal models can potentially enable improved studies of intestinal function in an 
ethically and well controlled manner, in particular for studies of cellular growth and 
proliferation [10], drug absorption [77] and host-microbial interactions [8].   
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The challenge is to construct a synthetic in vitro model that is topographically, 
mechanically and chemically similar to native tissues. The small intestine is a dynamic 
organ, displaying a structurally complex array of surface features that are home to a 
confluent layer of many different cell types that allow it to perform its primary 
functions of digestion and absorption (Figure 1.1). The circular folds of the intestinal 
mucosa, with fingerlike protrusions of up to 1.5 mm in length (intestinal villi) 
extending out into the lumen, form an intricate 3D environment. Each villus has 
lamina propria (loose connective tissue) as a core where the blood capillary network, 
lymphatic vessel, nerve fibers and various cells of the immune system are located [6, 
22]. Small intestinal stem cells which reside in crypts of Lieberkühn differentiate into 
four different small intestine epithelial cell types including enterocyte cells (absorptive 
cells), goblet cells, enteroendocrine cells and paneth cells. While forming tight 
junctions as a barrier between the lumen and lamina propria, the small intestinal 
epithelia undergo vigorous cell proliferation and differentiation processes where cells 
on the villi are renewed every 4-5 days [72].The small intestine is also heavily 
populated with microorganisms [39], which increase in concentration along the length 
of the intestine from 104 cells/g in the duodenum to 1012 
 
cells/g in the colon [35]. In 
addition to the complex topographical and cellular environment, the human intestine 
exhibits mechanically active peristalitic motions and fluid flow (mediated by the 
intestine’s own nervous system and smooth musculature), which strongly affect the 
microenviroment and surface morphology. 
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There exists a wide variety of models designed to study intestinal function, from small 
scale systems including simple porous cellular supports and microfluidic devices to 
large bioreactors. Each model has its own strengths and weaknesses in terms of 
complexity, and therapeutic relevance. This review aims to introduce the reader to the 
principal considerations for constructing a realistic in vitro intestinal model: including 
the different cell types, biomaterials and mechanical devices available. In addition, 
this review will give an overview of the current status of artificial small intestinal 
engineering for studying both intestinal function and host-microbial interactions. 
 
 
Figure 1.1 Cross section of a small intestinal villus 
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SMALL INTESTINAL EPITHELIUM: CELLULAR CONSIDERATIONS 
Perhaps the one of the most important considerations for the construction of an in vitro 
intestinal model is the cellular composition. At its simplest, a single cell type can be 
used for studying cellular responses to surface topography and/or environmental cues; 
however, models consisting of multiple phenotypes are desirable for the dynamic 
study of cellular interactions. Cell culture techniques are continually advancing, 
allowing for the co-culture of a variety of cell types on suitable surface supports. 
 
Enterocytic cell lines 
Enterocytes are the most abundant cell type among the intestinal epithelium, with each 
cell exhibiting a brush border membrane of up to 3000 microvilli upon differentiation 
[15]. The brush border also produces digestive enzymes such as peptidases and 
disaccharidases [65], as well as various nutrient transporters including sugar, amino 
acids, vitamins and minerals [18]. As the main cellular constituent of the small 
intestine, enterocytic cell lines form the basis of the simplest in vitro intestinal models. 
The most common and extensively studied is the human epithelial colorectal 
adenocarcinoma cell line (Caco-2) [26]. When forming a monolayer, Caco-2 cells can 
spontaneously differentiate into columnar and polarized cells that possess many 
similar characteristics of small intestinal enterocytes, including tight junction and 
microvilli formation as well as intestinal transporter and digestive enzyme expression 
[26, 53]. Caco-2-based intestinal models are thereby widely used for investigating 
functionalities of different intestinal transporters, determining nutrient bioavailability 
and predicting oral drug absorption efficiency [3, 25, 45]. Additionally, Caco-2 cells 
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can be converted into M cells in vitro by culturing lymphoid cells at their basolateral 
side. When cultured in this way, Caco-2 cells are capable of transporting antigens in a 
manner similar to M cells [31]. 
 
However, since Caco-2 cells are derived from the colon, rather than the small 
intestine, they have significantly different gene transcriptional profiles compared to 
native host upper intestinal cells, suggesting there may be key differences in enzymes 
and transporter availability between the two [69]. It has also been speculated that 
Caco-2 monolayers exhibit diminished porosity, as studies have shown they have 
increased trans epithelial electric resistance (TEER) compared to human small 
intestinal epithelium. Poor porosity would also explain the poor paracellular drug 
permeability correlations between in vivo and in vitro models using Caco-2 cells [3, 
55]. Cell lines such as the Madin-Darby canine kidney (MDCK) and the rat intestinal 
2/4/A1 have been considered as an alternative for in vitro intestinal models due to 
their low monolayer TEER values [29, 71].  However, a recent study found that Caco-
2 monolayers and MDCK monolayers have similar pore sizes and only 2/4/A1 
monolayers present a porosity that is  similar to human intestinal epithelium [41]. 
 
Goblet cell lines 
Goblet cells secrete various glycoproteins called mucins, which are the main 
component of the intestinal mucus layer. While providing defense of intestinal 
epithelium against excessive mechanical stress and toxic chemical agents, the mesh-
like network of mucin also prevents intestinal microbial invasion without impeding 
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nutrient transport [34]. Besides mucins, goblet cells also secrete intestinal trefoil factor 
peptides and resistin-like molecule β, which are both involved in mucin stabilization 
and mucin secretion regulation [17]. Due to the critical function of a mucin layer in 
small intestinal immunity, more complex in vitro models can benefit from co-culture 
with goblet cell lines (such as HT29-MTX) in addition to enterocytes [74]. Originally 
isolated as an undifferentiated human colon carcinoma cell line, HT-29 was initially 
used to mimic intestinal enterocytes when cultured under selective conditions [52]. 
However, later studies found that HT29 could differentiate into mucus producing, 
goblet-type cells after stimulation with the anticancer drug methotrexate (MTX). This 
MTX adopted cell line (HT29-MTX) retained the differentiated phenotype even in 
MTX-free medium [38]. The TEER values of co-cultured monolayers of HT29-MTX 
and Caco-2 have been found to be lower than purely Caco-2 cultures, which also 
provided paracellular drug permeability that is more similar to the case in vivo, 
although the improvement was limited [73]. 
 
Besides drug permeability determination, Caco-2 HT29-MTX co-culture models have 
also been used for studying iron bioavailability, since mucus layers are involved in 
iron absorption [45]. More recently, lymphoid cells were added to the basolateral side 
of a Caco-2/HT29-MTX co-culture model to stimulate M cell conversion. This tri co-
culture model was used to investigate nanoparticles effects on iron absorption [44]. 
Moreover, HT29-MTX cultures provided in vitro evidence that mucus production is 
linked to bacterial signaling, and mucus layers play an important role in bacterial 
adhesion as well as small intestinal epithelium inflammation [36, 49, 66]. 
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Enteroendocrine cell lines 
Enteroendocrine cells represent less than 1% of the entire intestinal epithelial 
population, although there are up to 15 different subtypes [68, 72]. Enteroendocrine 
cells are highly sensitive to luminal contents, and as such more than 30 hormones are 
released in response to specific stimuli [2, 11], which enable regulation over small 
intestinal motility, blood flow and secretion [11, 28]. The availability of a human 
enteroendocrine cell is rare for use in in vitro models, therefore immunoreactive 
alternatives including murine intestinal tumor cell lines such as STC-1 and GLUTag 
are often used [19, 60]. Both cell types have been exploited to study mechanisms of 
hormone secretion, such as cholecystokinin and glucagon-like peptide-1 in vitro [23, 
30, 64]. STC-1 has also been found to produce ‘bitter taste’ receptors, which provided 
evidence to suggest that the small intestinal epithelia are involved in overall taste-
sensing mechanisms [75]. 
 
Crypt cell lines 
In vitro crypt cell lines have been established and extensively used to understanding 
small intestinal epithelium differentiation. For example, rat small intestinal epithelial 
cells have been isolated and established for subculture in vitro [56]. Among these rat 
small intestinal epithelial cell lines, IEC-6 has been the most frequently used cell type 
to investigate differentiation signals. Under normal culture conditions, IEC-6 retains 
the characteristics of undifferentiated small intestinal crypt cells [56].  When cultured 
on the extracellular matrix Matrigel, IEC-6 cells become more differentiated and 
exhibit several enterocyte characteristics such as being polarized with microvilli on 
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their apical side and expressing digestive enzymes [12].  Recently, a clone of IEC-6 
which over expresses transcription factors Cdx2 and HNF-4α not only obtained 
differentiated enterocyte characteristics but also expressed mucus related gene mucin 
3 when cocultured with intestinal mesenchymal cells in vitro [43]. Moreover, a clone 
of IEC-6 expressing the insulin promoting factor PDX-1 had pancreatic β -cell like 
characteristics including secreting insulin, which when transplanted in adult diabetic 
rats showed potential as a diabetes therapy [76]. 
 
In vitro crypt cell lines were also established from human small intestine. For 
example, the HIEC cell line, which retains undifferentiated crypt cell characteristics 
was developed from human small intestine [51]. Highly similar to IEC-6, HIEC was 
used to investigate the function of transcription factors Cdx2, HNF-1α and GATA-4 in 
enterocyte differentiation.  Combining expression of these three transcription factors 
made HIEC differentiate into an enterocyte morphology with digestive enzyme gene 
expression [7]. Interestingly, Sato et al. [62] have successfully demonstrated that a 
single mouse stem cell could not only differentiate into the four different small 
intestinal epithelial cell types but also could form crypt-villus like structures in vitro. 
Similarly, Spence et al. [67] have differentiated human pluripotent stem cells into 
crypt-villus-like 3D organoids that appear to maintain the complete function of small 
intestinal epithelium. These novel stem cell culture methods not only provide new 
insight into small intestinal development but also greatly improve in vitro model 
capabilities. 
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SMALL INTESTINAL TOPOGRAPHY: CELLULAR SUPPORTS AND 
BIOMATERIAL CONSIDERATIONS 
Cultures of intestinal cells usually make use of a porous scaffold to provide a surface 
for cell seeding and proliferation, as well as the mechanical/physical support 
(stiffness) needed for cell growth. A common method is to seed on the classic 
transwell insert, which has a micro-porous plastic membrane as the growth surface 
[26, 27]. These transwells are produced via a track-etching process and have well 
controlled pores that range from 0.4µm to 8µm in diameter, which allow media and 
molecules to pass through freely while blocking epithelial cell migration [21].  The 
apical side of a transwell is considered to be the luminal side whereas the basolateral 
side of transwell is termed the submucosal side (Figure 1.2A). Compared to a normal 
cell culture well plate, which has a non-porous growth surface, the porous membranes 
make co-culturing of multiple cell layers possible as the cells on the bottom 
(basolateral) layers will not be deprived of nutrients and oxygen. 
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Figure 1.2 Schematic illustration of in vitro small intestinal models. (A) Transwell 
insert (B) Porous 3D scaffold 
 
Although flat porous inserts have enhanced intestinal cell culture capabilities, cells 
seeded onto flat supports exhibit markedly different phenotypes to cells in vivo [63], 
as cell physiology, morphology and behavior is often determined by the physical and 
chemical state of the extracellular environment in which they grow. Cells in a 3D 
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villous environment will experience radically different gradients of nutrients and 
oxygen than cells grown on a flat surface [24], which will affect cell behavior and 
differentiation, as well as spatial differences which will affect individual cell-cell and 
cell-matrix contacts and communication [14, 42].  Porous 3D scaffolds are therefore 
becoming more commonplace in intestinal engineering (Figure 1.2B). For example, 
using microfabrcation techniques and hydrogel biomaterials, Sung et al. [70] 
constructed artificial 3D villi composed of hydrogel scaffolds in the same shape, size 
and distribution as human intestinal villi. A 3D human small intestinal in vitro model 
has been developed by Yu et al. [77] based on this technique, which presented unique 
differentiation morphology of Caco-2 monolayers along the crypt-villus axis. 
Paracellular drug permeability determined from this 3D in vitro model was more 
highly correlated with that of perfused human intestine than a 2D (flat) model.  
Further, TEER measurements in the 3D model were closer to rat TEER values than 
were the same measurements made in the 2D case [77]. This suggests that missing 
villous geometry instead of the smaller porosity of Caco-2 monolayers is the main 
reason for the poor paracellular drug permeability correlations in the conventional in 
vitro model. Along the same lines, Pusch et al developed [54] a dynamic 3D in vitro 
co-culture model by culturing Caco-2 cells with primary human microvascular 
endothelial cells (hMECs) on decellularized pig small intestine segments. While 
higher dipeptidase enzymatic activity and improved paracellular drug permeability 
was found in this 3D tissue model no TEER values were measured in this system. 
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HOST-MICROBIAL INTERACTIONS: CURRENT STATE OF PLAY 
Perhaps one of the greatest challenges facing intestinal engineering is the ability to 
construct an accurate in vitro model that has the ability to support both host 
mammalian cells and microbial organisms. Short term co-culture models have 
provided evidence that host cell growth, morphology, differentiation and secretion 
systems are affected by the presence of microbes in the same environment. Many in 
vitro studies have focused on bacterial adhesion to intestinal cell lines using simple 
transwell plate co-culturing techniques. For example, commensal bacteria such as 
Lactobacillus have been found to produce proteinaceous adhesion factors, which 
enable them to bind the mucus secreted by goblet cells such as HT29-MTX [8]. 
Brovko et al. [9] applied a simple yet direct method to quantitatively assess adherence 
and growth of pathogenic and non-pathogenic E. coli in the presence of mammalian 
cells seeded on microwell plates by using bacterial strains containing bioluminescent 
T7 plasmids. They found that bacteria in direct contact with HeLa cells experienced 
greater growth than control strains incubated with FBS. In addition, bacterial 
translocation across Caco-2 monolayers has been found to be related to tight junction 
integrity, with greater levels of translocation from a short term culture with lower 
TEER levels [13]. Short-term co-culture models on flat inserts have also been used to 
elucidate the beneficial effects of probiotic microorganisms against harmful 
pathogens, as they stimulate the native epithelial cells to improve barrier function [37, 
59]. 
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However, these simple co-culture models provide limited data as typically long-term 
prolonged co-culture of intestinal cells with bacteria is poorly sustained due to 
differing growth rates. Microbes, as a rule, tend to multiply at a greater rate than host 
cells which can lead to bacterial overgrowth and accumulation of harmful metabolites 
[58]. A working intestinal model should enable consistent control over the growth rate 
of both mammalian and microbial cell populations in order to realistically mimic the 
host intestine. With this proviso in mind, Kim et al. [33] developed a protocol for 
culturing host cells and commensal bacteria in a microfluidic device. Using 
pneumatically-controlled trapping, they were able to hold and segregate the different 
cell types, creating bacterial “islands” of E. coli surrounded by HeLa cells, with 
separate inlet and outlet ports for providing growth media and removing waste.  
Additionally, they were able to use this device to study the attachment and 
proliferation of model pathogens (enterohemorrhagic E. coli) onto HeLa cells, making 
studies more realistic due to the added presence of commensal bacteria. They 
envisaged that this model can be used for screening pre and pro-biotic strains, as well 
as investigating the role of specific pathogenic infectious signals in intestinal 
disorders.  
 
By using more complicated microfluidic approaches, Kim et al. [32] created an “gut 
on a chip” device that enabled the co-culture of Caco-2 cells and Lactobacillus 
rhamnosus GG (LGG) on a porous membrane, with fluid flow channels for sustained 
cell culture and cyclic strain for mimicking peristaltic motions. Using a combination 
of immunofluorescence, enzyme assays and TEER measurement, they found that 
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cyclic strain caused an increase in Caco-2 elongation, differentiation and paracellular 
permeability. Additionally, they found that the LGG cells remained adherent for 1 
week, and that the addition of the microbes actually increased tight junction formation, 
as shown through TEER analysis. They theorized that fluid flow movement 
accompanied by peristaltic motions prevents the accumulation and overgrowth of 
microbes that might otherwise affect the viability of intestinal cells, by enabling the 
removal of unattached/dead cells and harmful organic acids. 
 
As well as providing a platform for the study of host-microbial interactions, small 
intestinal models can potentially aid in the study of gene transfer in the gut. The 
transfer of antibiotic resistance genes between intestinal microbes can have a dramatic 
effect on both the ecology and evolution of the microbial population, particularly as 
acquired genes may be advantageous, allowing colonization of otherwise hostile 
niches and/or improved pathogenicity. This can have serious detrimental effects on 
human health, leading to chronic, poorly treatable infections [61]. In recent years, 
much of the research into microbial conjugation in the gut has been focused on in vivo 
experiments in animals. Bacterial donors and recipients have been cultured in vitro, 
followed by inoculating directly into live animals and then subsequent detection 
through faecal matter or animal sacrifice [4]. However, in addition to being expensive 
and unreliable, live animal models make it difficult to observe and document plasmid 
transfer and gene acquisitions as they occur in real time.  In vitro small intestinal 
models are small scale, yet they may enable us to answer questions from which 
previous research has elicited conflicting data. For example, Feld et al. [20] found a 
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higher rate of transfer in gnotobiotic rats than on filters suggesting that the gut 
environment facilitates transfer relative to filter matings; whereas Licht et al. [40] 
concluded that in the mouse gut only a small proportion of the bacteria exchange DNA 
near the epithelial cells perhaps because they behave more like an unmixed biofilm. 
Emulating the physical and cellular make-up of our intestines could therefore create an 
opportunity to answer these questions more fully, and be a major breakthrough in the 
study of antibiotic resistance and chemical communication between bacteria and 
epithelia.    
 
CONCLUSIONS 
Since firstly invented more than two decades ago, in vitro small intestinal models have 
been extremely useful in predicting drug oral absorption efficiency as well as 
understanding small intestinal epithelium differentiation and functionality. Benefited 
by recent developments in stem cell and microfabrication techniques, better in vitro 
models with physiologically relevant small intestinal strucutres as well as excellular 
microenvironments are being realized. Since we still know little about GI host-
microbial interactions, accurate in vitro small intestinal models could be a cutting-
edge tool to explore this area and possibly provide therapies for intestine-related 
diseases.     
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ABSTRACT 
Here we describe a simple and efficient method for fabricating natural and synthetic 
hydrogels into 3D geometries with high aspect ratio and curvature. Fabricating soft 
hydrogels into such shapes using conventional techniques has been extremely difficult. 
Combination of laser ablation and sacrificial molding technique using calcium alginate 
minimizes the stress associated with separating the mold from the hydrogel structure, 
and therefore allows fabrication of complex structures without damaging them. As a 
demonstration of this technique, we have fabricated a microscale collagen structure 
mimicking the actual density and size of human intestinal villi. Colon carcinoma cell 
line, Caco-2 cells, were seeded onto the structure and cultured for 3 weeks until the 
whole structure was covered, forming finger-like structures mimicking the intestinal 
villi covered with epithelial cells. This method will enable construction of in vitro 
tissue models with physiologically-realistic geometries in at microscale resolutions. 
 
INTRODUCTION 
3D hydrogel cell cultures have been of a great interest in biomedical engineering 
recently [1, 7]. Culturing cells in 3-dimensional space has been shown to provide cells 
with a more physiologically realistic environment, including cell-to-cell and cell-to-
matrix interactions and proper chemical and mechanical signaling. Adequate 3D cues 
allow cells to exhibit more authentic functions, compared to traditional 2D cell 
cultures, which are known to be significantly different from their in vivo counterparts. 
As the importance of 3D cell culture is growing, various hydrogels have been 
developed as scaffolds for 3D cell culture. Hydrogels are hydrophilic polymers, with 
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their major fraction being water, and thus provide a cell-friendly environment as well 
as mechanical support for cell growth and differentiation. A large number of synthetic 
and naturally derived hydrogels exist, with a wide range of mechanical and chemical 
properties [23]. Typically, cells are encapsulated within or cultured on the surface of 
these hydrogels. For cell-laden hydrogels to correctly reproduce the biological 
functions of in vivo tissues, it is important to accurately mimic the 3D geometry of the 
native tissue in micro/nanometre resolution [11, 13, 15, 22]. 
 
For this reason, microscale fabrication of hydrogel structures has been of a great 
interest in biomedical applications, and several methods have been developed that 
enable synthesizing hydrogels with controlled features [12, 27]. The most well-known 
methods include replica molding, photo-polymerization, and direct printing [12, 25, 
27]. While these methods can control the feature size to microscale resolutions, they 
are typically limited to the fabrication of low to medium aspect ratio structures, with 
perpendicular shapes. It is technically challenging to fabricate more complex 
structures, such as a structure with a high aspect ratio or a curvature, which are 
frequently encountered in nature. Examples include long bundles in native skeletal 
muscles [4] and the villi structure lining the apical side of the gastrointestinal (GI) 
tract [29]. Conventional replica molding is not suitable for fabrication of such shapes, 
since an attempt to separate the soft hydrogel scaffold from a mold would easily result 
in destruction of the structure. While the photo-polymerization method has a 
resolution of several micrometers, it cannot create curved 3D shapes, and is limited to 
photo-polymerizable hydrogels only [21]. Direct printing methods can be used for 
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free-form fabrication of arbitrary shapes, but are typically suitable for low-resolution 
applications (hundreds of micrometers), cannot make curved shapes, and require 
expensive equipments [10, 16].  
 
In this study, we report a novel method for fabrication of 3D structures made from soft 
hydrogels. Laser ablation creates a controlled array of deep holes in a plastic mold, 
which is used to make a Poly (dimethyl sulfoxane) (PDMS) mold with the desired 
features. The PDMS mold is used to create a secondary mold made of calcium 
alginate, which is subsequently dissolved after forming a 3D structure with the final 
hydrogel (Figure 2.1). Using calcium alginate as a sacrificial mold eliminates the need 
for applying force for separation of the hydrogel structure, and enables creation of a 
hydrogel scaffold with a high aspect ratio and curvature. As a demonstration of this 
technique's feasibility, we have fabricated a collagen scaffold mimicking the 3D 
geometry of gastrointestinal tract villi. Then we cultured Caco-2 cells , human 
epithelial colorectal adenocarcinoma cells , on the scaffold for three weeks, which 
resulted in cell-coated hydrogel villi with a striking similarity to the human jejunal 
villi (Figure 2.5 and 2.7). The novelty of this method lies in the use of alginate 
hydrogel for sacrificial molding under physiological conditions (pH, temperature). 
These steps enable creation of high aspect ratios and the use of “cell-friendly” 
hydrogels that would be unstable at higher temperatures or non-physiological pH. 
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Figure 2.1 Overall fabrication process. The first plastic mold is created by laser 
ablation, from which the PDMS reverse-mold is created. The alginate second mold is 
made from the PDMS, and dissolved after the final hydrogel structure is made. 
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MATERIALS AND METHODS 
 
Laser ablation and PDMS mold fabrication 
Poly (methyl methacrylate) (PMMA) was purchased from Ithaca plastics Inc (Ithaca, 
NY). The UV laser micromachining system Resonetics Maestro 1000 (Resonetics, 
Nashua, NH) was used to fabricate high-aspect ratio holes in PMMA [14]. The laser 
energy was stabilized at 50 mJ by using the energy stable function. A stainless sheet 
with 4 mm diameter circle was used as laser shutter. The laser pulse rate was set at 
75PPS (pulse per second), and the pulse number was set to 1100. At these parameters, 
the depth of hole was estimated to be approximately 506 um, which was later 
confirmed by confocal microscopy. The distance between rows and columns was set 
to be 200 μm for 25 holes/mm2
 
 density. To measure the depth of hole, a drilled 
PMMA sheet was coated with gold by a gold sputtering system (Polaron) for 30 min 
to generate detectable signals. The depth was measured by Wyko HD-3300 noncontact 
surface height measurement system (Veeco Instruments Inc, Tucson, AZ). A linear 
relationship was found between laser pulse number and hole depth (Figure 2.3). 
PDMS monomer and curing agent (Sylgard 184, Dow Corning, Midland, MI) were 
mixed at 7:1 ratio, and poured onto the PMMA with holes. After degassing to remove 
bubbles and ensure the PDMS prepolymer solution filled up the holes, PDMS was 
cured at room temperature overnight. After curing, the PDMS mold was slowly peeled 
off. 
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Surface coating of PDMS villous scaffold  
PDMS scaffold was treated by oxygen plasma (Harrick Plasma, Ithaca, NY) for 60 
seconds. Right after plasma treating, PDMS scaffold was coated with 200µg/ml type I 
collagen (BD Biosciences, San Jose, CA) in 0.02N acetic acid for 2 hours in 37 °C 
incubator. After coating, PDMS scaffold was washed by PBS buffer for 3 times and 
kept in 4 °C until use. 
 
Cell culture 
Caco-2 cells (ATCC, Manassas, VA) were maintained in Dulbecco’s Modified 
Eagle’s Media (DMEM, Cellgro, Manassas, VA), with 10% fetal bovine serum (FBS, 
Invitrogen, Carlsbad, CA) and 1X anti-biotic anti-mycotic (Invitrogen). Human 
mesenchymal stem cells (hMSCs, Lonza, Basel, Switzerland) were maintained in 
mesenchymal stem cell growth medium (Lonza). Rat small intestinal epithelial crypt 
cells IEC-6 Cdx2 HNF4-α (a kind gift from Professor François Boudreau, Universite´ 
de Sherbrooke) were maintained in DMEM containing 0.1 U/ml insulin, 4.5 g/l D-
glucose, 25 mM HEPES, 1% penicillin-streptomycin and 10% FBS. For co-culture, 
Human mesenchymal stem cells were cultured on PDMS scaffold for 14 days, then 
IEC-6 Cdx2 HNF4-α cells were seeded on top at 1 × 105 cells/cm2
 
 seeding density. 
After seeding, cells were maintained in co-culture media, which contained DMEM 
with 0.1 U/ml insulin, 4.5 g/l D-glucose, 25 mM HEPES, 1% penicillin-streptomycin, 
10% FBS and 50 μg/ml ascorbic acid. The media was replaced every 2 days during the 
culture. 
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Fabrication of alginate mold and collagen/PEG-DA scaffold 
For fabrication of an alginate mold, a PDMS stamp with villi structure was made first. 
An aluminum gasket rig was designed based on the previously reported method using 
a gasket for fabricating microfluidic channels in calcium alginate[6]. It consists of a 
base frame (G1) with a recess (7mm x 7mm, 0.7 mm depth), a middle frame for 
holding PDMS (G2), and the top frame (G3). The three frames were secured with 
screws. The PDMS stamp was cured overnight at room temperature to avoid 
deformation of aluminum from heating. After curing, G1 was removed, and the PDMS 
villi structure (made from the PMMA mold) was glued on top of the cured PDMS. 
Uncured PDMS prepolymer solution was used as glue. The rig was left at room 
temperature overnight until the PDMS glue set. After the PDMS villi piece was fully 
glued, an aluminum gasket (G4) was secured on top of the PDMS stamp. G4, a square 
piece with a 10 mm by 10 mm hole, is used as a gasket for holding the alginate mold. 
Sterile-filtered 2.5% sodium alginate (10/60 sodium alginate, FMC biopolymer, 
Philadelphia, PA) was inserted into hole in G4. The top was covered with a 
polycarbonate membrane (G5, 8 μm pore size, 25 mm diameter, Fisher Scientific, 
Pittsburg, PA) and a perforated aluminum piece (G6) with 1mm diameter holes. An 
aluminum gasket (G7), which works as a reservoir for calcium chloride solution is 
secured on top, and 3 ml of 60 mM calcium chloride solution was inserted into the 
reservoir. After incubating at room temperature for 4 hours, a gasket with alginate 
mold (G4) was separated from other gasket pieces. Collagen or PEG-DA pre-gel 
solution (5 mg/ml final concentration in 0.1% acetic acid for collagen and 20% (w/v) 
for PEG-DA with 0.5% 2,2’-Azobis(2-methylpropionamidine) dihydrochloride as a 
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photoinitiator) was placed in the alginate mold. Collagen pre-gel solution was 
neutralized with 1M NaOH and kept in ice before the insertion. Collagen was gelled 
by raising the temperature to 37 °C, and PEG-DA was polymerized by exposure to 
UV for 30 minutes in a UV crosslinker (Spectronics Corporation, Westbury, NY). The 
collagen was further crosslinked with 0.1% glutaraldehyde for 4 hours. After the gel 
was made, the alginate mold was dissolved using 60 mM EDTA solution for 3 hours 
at room temperature. The whole process is summarized in Figure 2.2. 
 
Figure 2.2 Summary of fabrication process. A PDMS stamp holds the PDMS villi 
structure on top, where sodium alginate is placed and cured with a calcium chloride 
solution. After curing alginate, collagen is inserted into the alginate mold and 
crosslinked. The sacrificial alginate mold is later dissolved with an EDTA solution. 
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Cell seeding and cell staining on collagen scaffolds 
After fabrication, collagen scaffold was incubated in 5% L-glutamic acid for 48 hours 
at room temperature to reduce the cytotoxicity of glutaraldehyde and restore the 
biocompatibility [9]. Then the scaffold was washed in PBS three times, and incubated 
in PBS until cell seeding. After trypsinization, live cells were counted and cells were 
resuspended in fresh medium to the final concentration of 1x105~5x105
 
 cells/ml. A 
drop of cell suspension was placed on top of the collagen scaffold and incubated for 
30 minutes before medium was added. After cell seeding, the collagen scaffold was 
maintained in a cell culture incubator with the medium changed every two days. 
Depending on the initial seeding density, cells will cover the collagen scaffold in 7~10 
days. After the collagen scaffold was covered, cells were fixed with formaldehyde, 
washed with PBS, and then stained with Alexa Fluor 488 phalloidin(Invitrogen) and 
TO-PRO-3 (Invitrogen). Fluorescently labeled phalloidin is a high-affinity probe for 
F-actin and TO-PRO-3 is a nucleic acid stain. Confocal images were taken with Leica 
SP2 confocal microscope (Leica Microsystems, Bannockburn, IL) and 3D image was 
rendered using Volocity (Perkinelmer, Waltham, MA). To maintain sterility, all gasket 
pieces were autoclaved prior to use and the gasket assembly and cell seeding was done 
in biosafety cabinet. 
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RESULTS 
Fabrication of PMMA mold, PDMS villi and hydrogel scaffolds 
 
Figure 2.3 Measured depth of holes in PMMA vs. laser pulse number 
 
Laser ablation was used to create an array of holes on a plastic mold. By controlling 
the pulse rate and the pulse number of the laser, it was possible to control the depth of 
the holes to be approximately 500 micrometer (Figure 2.3). The density and the depth 
of the holes were based on the actual density and the geometry of the human GI tract 
[26]. The bright-field microscope images of the fabricated plastic mold, the PDMS 
villi, alginate second mold, and the final collagen scaffold are shown in the Figure 2.4. 
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Figure 2.4 (A) PMMA surface with holes. There are 25 holes in 1mm2
 
. Each hole has 
oval shape due to the melting effect of laser.  The longer axis of the oval is about 200 
µm, and the shorter axis is about 160 µm. (B) PDMS surface with villi structures (C) 
Alginate mold with holes (D) Collagen scaffold with villi structures. The scale bars 
are 0.2mm. 
Curing PDMS on the plastic mold and peeling off the PDMS resulted in PDMS villi 
structures. As can be seen in Figure 2.5A, the PDMS villi faithfully reproduced the 
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originally intended geometry. Using the PDMS villi as the base template, an alginate 
gel was formed on the PDMS villi and separated to create the secondary mold. For this 
process, a custom-designed aluminium gasket was made to hold the hydrogels tightly 
against the PDMS villi (Figure 2.2). This gasket also minimized deformation of the 
alginate mold during gelling, and allowed precise control of the thickness of the 
alginate and final hydrogel structures. 2.5–4% alginate was used, which was 
sufficiently rigid to allow easy separation of the alginate mold from the PDMS villi. 
The alginate mold consists of an array of holes, with the same geometry as the original 
plastic mold, which also makes it easier to separate without destruction of the features. 
 
For the final hydrogels, two types of hydrogels were used, collagen and polyethylene 
glycol diacrylate (PEG-DA), which are one of the most widely used natural and 
synthetic hydrogels for cell culture, respectively. Collagen is the most abundant 
protein in mammals, and is frequently used as a scaffold for cultures of various cell 
types [24]. PEG-DA is a synthetic, biocompatible hydrogel widely used for hydrogel 
cell culture [3]. Figure 2.5B shows an image of a typical structure made with 0.5% 
(w/v) collagen. Figure 2.5C shows the same structure made in 20% PEG-DA. In both 
cases, the height of the structure was about 450–500 mm, and the aspect ratio was 
close to 5. This verifies that the serial molding process replicates the 3D geometry 
accurately. 
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Figure 2.5 (A) SEM image of the PDMS villi structure. (B) Confocal microscope 
image of the collagen scaffold after 3D rendering. (C) Confocal microscope image of 
the PEG scaffold after 3D rendering. 
 
Cell culture on PDMS villous scaffold 
To demonstrate using the villi structure as a 3D scaffold for cell culture, we selected 
the Caco-2 cell line, which originated from human colon carcinoma, and is widely 
used as an in vitro model of gastrointestinal epithelial cell lining in drug absorption 
studies [2]. Caco-2 cells were seeded onto collagen coated PDMS villous scaffold 
first. After 4 days of culture, Caco-2 cells proliferated from the bottom to the half 
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height of the PDMS villus (Figure 2.6A). After 7 days of culture, Caco-2 cells covered 
the whole villus structure and reached confluency (Figure 2.6B), forming a 
differentiated cell morphology near the tip of villus (Figure 2.6D). On the 12th
 
 day of 
culture, higher cell density was observed on PDMS villus (Figure 2.6C). However, 
after 12 days of culture, Caco-2 cells failed to continue differentiating and detached 
from the PDMS villus.  
Apart from Caco-2 cell line, a co-culture system was also tested on the PDMS villous 
scaffold.  Human mesenchymal stem cells (hMSCs) were seeded onto PDMS villi and 
cultured for 14 days to mimic the mesenchymal layer under the small intestine 
epithelia [18]. Similarly to the Caco-2 cell line, hMSCs covered the whole villus 
structure after 7 days of culture (Figure 2.6E). IEC-6 Cdx2 HNF4-α cells promptly 
covered the whole hMSCs layer after being co-cultured on top of the hMSCs for 4 
days (Figure 2.6F). However, both cell lines began to detach from the PDMS villus 
and failed to continue differentiating during longer co-culture times. 
 
The limited cell survival time on PDMS villous scaffold can be explained by two 
reasons. Firstly, even though PDMS has relatively high gas permeability [5], the 
permeability of nutrients through PDMS, for example glucose, is limited, which 
makes it difficult for cells to uptake growth media from the basolateral side [17]. 
Secondly, PDMS itself lacks the capability of supporting cell attachment and 
proliferation. Once the collagen coated on the surface of PDMS villous scaffold is 
used up during the culture process, cells are likely to detach from the PDMS.  
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Figure 2.6 (A-D) Human carcinoma cells (Caco-2) were seeded on the PDMS 
scaffolds and allowed to grow to confluency (A: 4 days post seeding, B: 7 days, C: 12 
days, D: longtitudinal sections at 7 days). (E) Human mesenchymal stem cells 
(hMSCs) on the PDMS scaffolds. (F) Co-culture of hMSC cells and IEC-6 Cdx2 
HNF4-α cells on 3D scaffolds (4 days post IEC-6 seeding). Actin was stained green 
and nucleic acid was stained red. 1 unit = 22.1 µm. 
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Cell culture on collagen scaffold 
Due to the problems encountered by using PDMS scaffold, a collagen hydrogel was 
chosen to overcome the cell growth and basolateral side feeding problems due to its 
“cell friendly” and porous characteristics. We seeded the cells onto the collagen 
scaffold and cultured for up to three weeks. As cells proliferated, they invaded and 
covered the collagen villi. The image of the collagen structure covered with cells is 
shown in Figure 2.7A. The overall morphology of the cell-covered collagen structure 
shows a striking similarity to the scanning electron microscope image of human 
jejunal villi, shown in Figure2.7B as a reference [20]. The x–y slice image of stained 
cells (Figure 2.7C) shows that the cells proliferated around the collagen scaffold, 
forming a uniform coverage.  
 
 
Figure 2.7 (A) Confocal microscope image of Caco-2 cells on collagen scaffold, after 
staining for actin (green) and nucleic acid (blue). (B) Scanning electron microscope 
image of human jejuna villi (reproduced with permission from BMJ group [20] ). 
Confocal microscope image (x-y slice) of Caco-2 cells on the collagen scaffold, 
stained for actin (green) and nucleic acid (blue). 
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After cells completely covered the collagen surface, it was observed that the height of 
the collagen structure was reduced to about 250 μm, which is about half of the original 
size (Figure 2.8A). This change was not due to the instability of the collagen scaffold, 
as it remained intact while immersed in cell culture medium for three weeks (Figure 
2.8B). The decrease in height was probably caused by several factors, including the 
tension from the cells attached to the collagen matrix, degradation of collagen during 
invasion of cells into the matrix, and formation of a cell multilayer at the bottom 
surface. 
 
 
Figure 2.8 3D rendered image of collagen scaffold (A) covered with cells and (B) 
without cells  
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DISCUSSION  
This study describes a method for creating a hydrogel scaffold mimicking the 
microscale 3D geometries of biological tissues. This method offers several advantages 
over currently existing methods for microfabrication of hydrogels. Using alginate as a 
sacrificial layer is particularly advantageous since the alginate dissolving process is 
physiologically mild, and therefore compatible with applications involving cells. 
Furthermore, this method is relatively simple and the whole process can be carried out 
easily on a common lab bench or a biosafety cabinet for sterility. It does not require 
expensive or complicated equipments such as a cleanroom, which is required by most 
of microfabrication methods. Finally, this method should be compatible with various 
hydrogels, not only collagen and PEG-DA used in this study, and with other complex 
shapes of biological tissues. Although using a hydrogel as a sacrificial layer has been 
demonstrated previously [8], this method mainly focused on fabrication of a two-
dimensional microfluidic network. Our method is more versatile, as it allows 
fabrication of arbitrary 3D shapes. 
 
Physiologically realistic 3D models of intestinal villi may greatly improve in vitro 
drug absorption studies, allowing for improved predictability when compared to 
conventional Caco-2 monolayers [2]. In this study, cells were grown on the surface of 
a fabricated hydrogel scaffold to mimic the intestinal villi epithelium. Culturing 
additional cells encapsulated in the hydrogel scaffold would make an even more 
physiologically realistic in vitro model. For example, we further plan to encapsulate 
vascular endothelial cells inside the collagen scaffold to mimic the vascular structure 
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of the intestine. Another approach is to integrate the fabricated hydrogel structure 
within a microfluidic device to explore using the 3D villi model as a tool for drug 
absorption studies. Integration with a two-layer microfluidic device will enable 
simulation of basolateral and apical flow of the intestine. Through analysis of the flow 
on both sides one can study the dynamics of drug absorption through the GI tract. 
Examining the biological activity of the Caco-2 cells cultured on the 3D scaffold, 
possibly co-cultured with other supporting cell types [19, 28] will reveal the effect of 
having physiologically correct 3D geometry on cell functions. We believe that this 
method will contribute significantly to several research disciplines, such as tissue 
engineering, pharmaceutical sciences, and cell biology. 
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ABSTRACT 
We present a novel method for testing drug permeability that features human cells 
cultured on collagen based hydrogel scaffolds made to accurately replicate the shape 
and size of human small intestinal villi. We compared villous scaffolds to more 
conventional 2D cultures in paracellular drug absorption and cell growth experiments. 
Our results suggest that 3D villous platforms facilitate cellular differentiation and 
absorption more similar to mammalian intestines than can be achieved using 
conventional culture. To the best of our knowledge, this is the first accurate 3D villus 
model offering a well-controlled microenvironment that has strong physiological 
relevance to the in vivo system. 
 
INTRODUCTION 
Over two decades ago, a human intestinal in vitro model was developed by culturing a 
human colonic carcinoma cell line (Caco-2) on microporous filters [9]. When forming 
a monolayer under normal culture conditions, Caco-2 cells spontaneously differentiate 
into columnar and polarized cells that have similar resistance and permeability as 
small intestinal enterocytes [9, 16]. Since its development, this 2D model has being 
widely used for permeability testing of new drug candidates as well as investigating 
functionality of different intestinal transporters [1, 3, 4, 8]. While the 2D model has 
been proven accurate for transcellularly-transported drugs, the correlation between the 
2D model and the human intestine for carrier-mediated and paracellularly-transported 
drugs is poor [2, 4, 6, 13]. For drugs transported via the carrier-mediated pathway, 
research has demonstrated that poor correlations are cell line-related and that the 
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Caco-2 cell line can have significant differences in transport-related gene expression 
levels when compared to the human intestine [19]. For drugs absorbed via the 
paracellular pathway, poor correlations are mostly attributed to two factors: (1) the 
difference in tight junction formation between Caco-2 cell monolayers and human 
small intestine epithelia and (2) the lack of intestinal villi in 2D models[4]. Intestinal 
cell lines with leakier tight junctions have been used to improve the correlation to 
human intestines of paracellularly-absorbed drugs [7, 21]. However, recently it has 
been shown that Caco-2 cell monolayers have similar paracellular pore size 
distributions as human intestinal epithelia, even though, on average, the porosity of 
Caco-2 monolayers is smaller [14].  Taken together, these findings suggest that there 
may be an as yet undetermined role for the 3D microenvironment in controlling 
epithelial barrier function. 
 
Making use of newly developed microfabrication techniques and biocompatible 
materials, new in vitro models of the small intestinal microenvironment have been 
reported. For example, a microfluidic device fitted with a cell culture analog was 
recently used to mimic the human gastrointestinal tract on a microscopic scale [15]. In 
other work intestinal crypt-like topography was fabricated into a cell culture system, 
although the size of the crypt structures was significantly smaller than actual crypts 
[23]. We recently reported fabricating hydrogel structures with high aspect ratio and 
curvature at the micro-scale using a combination of laser fabrication and sacrificial 
molding [20]. However, despite recent advances no one has been able to demonstrate 
the relevance of the 3D environment to epithelial barrier function.  
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To begin to answer this question, we present here a new method for performing a drug 
permeability test that makes use of 3D biomimetic scaffolds to impart physiological 
relevance to an in vitro model. Intestinal villi scaffolds were fabricated using, first a 
CO2 laser to form an 8 by 8 mm2 villi array mold on polymethylmethacrylate 
(PMMA) sheet. The density of the villi mold was intended to simulate actual villi 
spacing at 25 villi/mm2
22
 and the depth of a single villous mold was approximately 565 
µm, which is in the physiological range of human small intestinal villi [ ]. A 
collagen scaffold was made from the mold using previously described techniques [20]. 
A well plate insert was designed to integrate the hydrogel scaffold into a standard 6-
well culture plate.  The goal of this study was to determine the role of the 3D 
microenvironment in establishing barrier function and to improve existing in vitro 
intestinal models by incorporating widely-available biomaterials. 
 
MATERIALS AND METHODS 
Laser fabrication 
Polymethylmethacrylate PMMA sheet (Ithaca Plastic, Ithaca, NY) was used as a 
template. A CO2
20
 laser system VersaLaser VLS3.50 (Versatech, USA) with controlling 
software Corel Draw X5(Corel, Mountain View, CA) was used, which gave a much 
higher etching capability than the UV laser used in previous work [ ].  An 8 mm by 8 
mm oval array with 25 ovals per square millimeter density was drawn using the 
software package. The long axis of a single oval is 100 µm, the short axis is 60 µm. To 
prevent over melting of the PMMA surface by the laser, the etch model was set as 
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VECT with 10% laser power, 100% laser speed and 1000 Pulses Per Inch (PPI). The 
PMMA mold was etched with different copy times in order to achieve an ideal depth. 
Hole depth was measured by an Olympus BX61 upright microscope system (Olympus 
Imaging America, Center Valley, PA) using the Z-series function. The final PMMA 
mold was made under this setting with 4 distinct etch times. 
 
Fabrication of collagen villi hydrogel 
The collagen villi hydrogel was fabricated using previously reported methods [20]. 
Briefly, a Polydimethylsiloxane (PDMS) villi structure mold was made from a PMMA 
mold. The PDMS villi mold was glued on an aluminum gasket to make an alginate 
reverse mold, which was cured with a 60 mM calcium chloride solution.  The collagen 
hydrogel scaffold was made by 5 mg/ml type I collagen (Sigma, St. Louis, MO) from 
the alginate reverse mold. After curing collagen at 37 °C with 0.3% glutaraldehyde 
overnight, the alginate mold was dissolved in a 60 mM EDTA solution. The collagen 
hydrogel scaffold was washed with PBS buffer for three days before use. The 2D 
collagen was fabricated using the same method but without villi structure in the 
PMMA mold. 
 
Cell culture 
The human colon carcinoma cell line Caco-2 (passage number 16-25, ATCC, 
Manassas, VA) was used in this study. Caco-2 cells were maintained in Dulbecco’s 
Modified Eagle’s Media (Mediatech, Manassas, VA), with 10% FBS (Invitrogen, 
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Carlsbad, CA) and 1X anti-biotic anti-mycotic (Invitrogen, Carlsbad, CA).  Caco-2 
cells were maintained in a 37 °C incubator with 5% CO2 gas. 
 
Design of well-plate insert 
Our well plate insert design was based on existing inserts so that they can be directly 
added to commercially available plates (Figure 3.1, Figure3.2). In this design, a 
hydrogel scaffold either with or without (as a 2D control) synthetic villi is placed in 
the bottom of the supporting structure and sealed by a size 10 O-ring (0.289 cm2 
sealing area) (Figure 3.1A). Screws were used to tighten the top gasket into the 
supporting insert, which allows the operator to apply the correct amount of pressure to 
the upper insert to make a seal.  A dye test was performed to insure that there was no 
leaking around the hydrogel (Figure 3.1B) and that the integrity of hydrogel was still 
intact after being sealed (Figure 3.1C). The whole insert is compatible with ordinary 6 
well culture plates (Figure 3.1D). The insert kit was autoclaved and assembled with 
the collagen hydrogel scaffold using sterile tweezers. Assembled kits were placed into 
six-well plates (one well at a time) using sterile tweezers. 
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Figure 3.1. Overview of the insert kit (A) Schematic of the insert design (B) Dye test 
result of the insert, an O-ring was used to completely seal the villous insert within the 
culture well and prevent short-circuiting around the test area. (C) When the 
scaffolding was removed from the culture well, the scaffolding layer did not rupture 
and the dye remained within the villous test area. (Arrow points to the O-ring sealing 
area) (D) An image of a modified well inserted in a 6 well plate. (Arrow points to the 
area actually covered by synthetic villi) 
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Figure 3.2 Pictures of insert kit. (A) Supporting insert (B) Upper insert and O-ring (C) 
Bottom supporting filter (D) Top gasket 
 
Dye test 
Collagen hydrogel scaffolds were assembled inside insert kits. NEON blue food dye 
solution (McCormick & Co, Hunt Valley, MD) was added to apical side in order to 
observe its diffusion to the basolateral side. After visually checking for leaks, the 
collagen hydrogel scaffolds were detached from the insert kits and inspected for 
integrity. 
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Trans Epithelial Electric Resistance measurement 
Trans Epithelial Electric Resistance (TEER) was measured with EVOM2 Epithelial 
Voltohmmeter with STX3 electrode (World Precision Instruments, Sarasota, FL). 
Electrodes were places on the apical and basolateral sides of the insert kits in order to 
measure TEER across the 2D and 3D cultures. Standard 0.4 µm pore size cell culture 
inserts (Corning Incorporated, Corning, NY) were used for measuring Caco-2 TEER 
under conventional conditions. 
 
Drug permeability test 
Drug permeability testing was conducted following a standard protocol [11] with the 
following adjustments. After being sealed into an insert kit, collagen hydrogel 
scaffolds were coated with 20 µg/mL Laminin (Sigma -Aldrich, St. Louis, MO) in 
37°C for 2 h. After being washed by PBS for three times, scaffolds were seeded with 
20 µL 1 × 106 cells/ml Caco-2 cells and incubated (37°C with 5% CO2 gas) for 1 h to 
allow cell attachment. After checking cell attachment, 1.5 mL  culture media was 
added into the apical side of the insert kit and 6 mL culture media was added to 
basolateral side. Media was exchanged 1 day after seeding and every 2 days during the 
experiment. Hank's balanced salt solution (Sigma-Aldrich, St. Louis, MO) was 
buffered with 25 mM HEPES and 0.35 g/L NaHCO3
20
 and adjusted to pH 7.4 to be used 
as HESS buffer in this experiment. The permeability test was conducted after 14 days 
culture because longer culture times resulted in shorter villous heights and multiple 
cell layers penetrating the villus scaffold [ ]. Prior to the permeability test, media 
was aspirated from both apical and basolateral sides and 37°C pre-warmed HESS was 
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added apically and basolaterally. The TEER value and cell monolayer morphology 
were checked to make sure that only scaffolds with no monolayer disintegration were 
used. The plates were incubated (37°C with 5% CO2 gas) on a 500 rpm orbital shaker 
(MTS 2/4 digital shaker, IKA@ Works, Wilmington, NC) for 15 min then HESS buffer 
was removed and the inserts were transferred to new six-well plates. Three hundred 
microliters 37°C Antipyrine (0.1 mM in HESS, pH 7.4) or Atenolol (2.0 mM in HESS, 
pH 7.4) solution was added to apical side of the inserts and 100 µL was immediat ely 
taken for measuring C0. Six milliliters 37°C HESS solution was added to the 
basolateral side to eliminate the hydrostatic pressure difference between the apical and 
basolateral chambers. The six-well plates were incubated (37°C with 5% CO2 gas) on 
a 500 rpm orbital shaker to minimize the impact of the unstirred water layer. At 
specific time intervals, a 3 mL sample was collected from the basolateral side and 
replaced by 3 mL 37°C HESS solution. For each permeability test at least, three 
samples were taken within a 2 h period. A 100 µL sample was taken from the apical 
side of the insert for measuring Cf
11
 at the last sample point. After completion of the 
permeability test, TEER was measured to insure that monolayer integrity was intact. 
The hydrogel scaffolds were then detached from the insert kit and fixed in a 4% 
formaldehyde solution for confocal scanning. The permeability coefficient was 
calculated based on a non-sink condition and only mass balances greater than 90% 
were used. Details of permeability coefficient calculation can be found in more detail 
elsewhere [ ]. Briefly, the permeability coefficient Papp
Papp=(dQ/dt) (1/(AC
 (cm/s) was calculated 
according to the follow equation:  
0)) 
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where (dQ/dt) is the rate of appearance of drug on the receiving side (µmol/s), A is the 
cross-sectional area of the barrier (cm2), and C0 is the initial drug concentration on the 
donor side (µmol). In this study, A is the O-ring sealing area, which is 0.289 cm 2
 
 for 
both 2D and 3D collagen. For conventional insert data, permeability tests were 
conducted after 14 or 21 days culture using 12-well plate inserts. Each permeability 
measurement was replicated 4 times. Student's t-tests were used to determine 
statistically significant differences. 
High performance liquid chromatography analysis 
High performance liquid chromatography (HPLC) was used to measure the drug 
concentrations in the permeability tests through a reverse-phase C18 column (250 ×  
4.6 mm2
. 
, 5 µm, Phenomenex, Torrance, CA) equipped with a photodiode array 
detector (210 nm-400 nm, Waters Corporation, Milford, MA). Elution A was aqueous 
0.1% trifluoroacetic acid (TFA) and elution B was acetonitrile in 0.1% TFA. A 
gradient of 5%-30% B at a flow rate of 1.0 ml/min was used, and the column was 
maintained at 25 °C. The absorbance was measured at 225 nm for Atenolol, and 254 
nm for Antipyrine, respectively 
Immunofluorescence 
Mouse small intestine paraffin sections were obtained from C57BL/6J (B6) male mice 
at 18 weeks age. Adult Human small intestine paraffin sections were obtained from 
Dr. David J. Hackam Lab at Children’s Hospital of Pittsburgh of UPMC as a gift. 
Paraffin sections were washed 3 times in xylene solution for 5 min each followed by 
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washes with 100%, 90% and 70% ethanol solutions for 5 min each respectively. 
Before the antigen unmasking, paraffin sections were washed in DI water twice. For 
antigen unmasking, paraffin sections were submerged in 0.01M citrate acid buffer pH 
6.0 in a sealed container and boiled in a steam cooker (Stanley Black & Decker, New 
Britain, CT) for 40 min. After three washes in DI water, paraffin sections were 
blocked by blocking buffer which contained 1X PBS buffer with 5% normal donkey 
serum and 0.3% Triton 
 
X-100 in room temperature for 60 min. Then paraffin sections 
were covered by 200 µl 1:50 diluted Alkaline Phosphatase antibody solution (4 µg/ml 
final concentration, catalog number L19, Santa Cruz Biotechnology, Santa Cruz, CA) 
and incubated at 4°C overnight.  After being washed by PBS for three times, paraffin 
sections were incubated with 200 µl 1: 1000 diluted Alexa Fluor 488 donkey anti-goat 
secondary antibody solution (2 µg/ml final concentration, Invitrogen, Carlsbad, CA) 
for 60 min in room temperature. Before imaging, paraffin sections were washed by 
PBS three times and stained by TO-PRO-3 (Invitrogen, Carlsbad, CA) for nucleic acid 
staining. 
Imaging and analysis  
Light microscopy was performed on a Leica DM IL LED invented microscope (Leica 
Microsystems, Buffalo Grove, IL). For confocal scanning, cell samples were stained 
by Alexa Fluor 488 phalloidin (Invitrogen, Carlsbad, CA) and TO-PRO-3 for actin 
and nucleic acid staining, respectively. Samples were scanned using a Leica SP2 
confocal microscope (Leica Microsystems, Buffalo Grove, IL) with Z-series 
capability. 3D rendering images and section pictures were assembled with Volocity 
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5.0 software (Perkin Elmer, Waltham, MA). Image analysis, cell density counting and 
villous parameter measurement were conducted with ImageJ software (NIH, Bethesda, 
MD). 
 
RESULTS 
Fabrication of PMMA mold using CO2
A CO
 laser 
2 
20
laser was used to fabricate PMMA mold. When compared to the UV laser used 
previously [ ], the CO2
 
 laser not only has relatively lower cost but also can provide 
greater control over etching.  The relationship between etch time and hole dept was 
determined (Figure 3.3) and each PMMA mold was etched 4 times to obtain an 
approximately 565 µm hole depth. 
Figure 3.3 Relation between etch time and hole depth.  The laser was running under 
10% laser power, 100% laser speed and 1000 Pulses per Inch (PPI). 
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Figure 3.4 (A) 10x magnification picture of 3D scaffolds covered with 14 days 
cultured Caco-2 cell monolayer sealed in a well insert before a permeability test. The 
larger black rings are holes on the bottom supporting filter. (B) 10x magnification 
picture of a Caco-2 monolayer growing on 3D villous scaffolds after permeability test. 
(C) 20x magnification picture of a Caco-2 monolayer growing on 3D villous scaffolds 
after permeability test (D) 20x magnification picture of a Caco-2 monolayer on 2D 
collagen after a permeability test 
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Cell monolayer integrity before and after the permeability test  
The insert design allows for observation of cell morphology on hydrogel scaffolds 
using ordinary 10x lenses in an inverted microscope (Figure 3.4A). After the 
permeability test, hydrogel scaffolds can be detached from the well insert and 
examined under higher magnification (Figure 3.4C, Figure 3.4D).  Caco-2 cell 
monolayer integrity was inspected before and after each permeability test. In all cases, 
cell monolayer integrity was found intact (Figure 3.4). 
 
Trans epithelial electric resistance (TEER) of cell monolayers  
Although close inspection found no monolayer disintegration, TEER of Caco-2 
monolayers grown on both the 2D and 3D collagen scaffolds was lower than that of 
Caco-2 monolayers grown on plastic inserts.  TEER of Caco-2 monolayers grown on 
3D collagen scaffolds was identical to that of perfused rat ileum [5], as well as human 
intestinal epithelia which was reported having TEER values ranging from 20 Ω·cm2 in 
the jejunum to 100 Ω·cm2 10 in the large intestine [ ]. 
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Figure 3.5 TEER of conventional Corning 0.4 µm polycarbonate cell culture insert 
with 14 days cultured Caco-2 cells (2D Conv), 2D collagen scaffolds with 14-day 
Caco-2 cell cultures (2D Collagen), 3D collagen scaffolds with 14-day Caco-2 cell 
cultures (3D Collagen) and rat ileum [5]. 
 
Comparing permeability coefficients of collagen scaffolds to conventional inserts 
To test drug permeability, two drugs representing different absorption properties were 
selected: Antipyrine (hydrophobic, rapidly and completely absorbed drug) and 
Antenolol (hydrophilic, slowly and incompletely absorbed drug) [13]. For Antipyrine, 
the collagen hydrogel used was found to be the most significant transport barrier 
(Figure 3.6A), which suggests that collagen may not be suitable for rapid drug 
permeability testing. For Antenolol, scaffolds without cells had faster permeability 
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coefficients than the scaffolds with cells, hence the scaffolding was not considered a 
limiting factor (Figure 3.6B). 
 
Figure 3.6 Comparing Permeability Coefficient of collagen scaffold to conventional 
insert. (A) Permeability coefficient of Antipyrine on Corning 0.4 µm polycarbonate 
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cell culture insert (Conv insert), insert with Caco-2 monolayer cultured 21 days (Conv 
insert with cells), 2D collagen scaffold (2D Scaffold) and 2D collagen scaffold with 
Caco-2 cells (2D Scaffold with cells) (B) Permeability coefficient of Atenolol on 
Corning 0.4 µm polycarbonate cell culture insert (Conv insert), insert with Caco-2 
monolayer cultured 21 days(Conv insert with cells) and 2D collagen scaffold (2D 
Scaffold). Inset of Conv insert with cells and 2D Scaffold intended to more clearly 
show the difference. 
 
The permeability coefficient of Caco-2 monolayers grown on 2D collagen scaffolds 
was not significantly different from the permeability coefficient of Caco-2 monolayers 
grown on conventional well inserts. Both of these values were at least 23 times lower 
than that of perfused human intestines (Figure 3.7) [12]. The permeability coefficient 
of Caco-2 monolayers grown on 3D collagen villi scaffolds was 13 times higher than 
that of Caco-2 monolayers grown on 2D collagen scaffolds and approximately more 
than half of the average value from perfused human intestines (Figure 3.7). 
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Figure 3.7 Permeability coefficients of Atenolol for perfused human intestine[12], 3D 
collagen scaffolds with 14-day Caco-2 cell cultures (3D Collagen), 2D collagen 
scaffolds with 14-day Caco-2 cell cultures (2D Collagen) and 2D Corning 0.4 µm 
polycarbonate cell culture insert with 14 days cultured Caco-2 cells (2D Conv). Inset 
is the permeability coefficients for just the 3D and 2D collagen inserts without cells 
(3D Scaffolds and 2D Scaffolds, respectively, 2D Scaffold is the same data used in 
Figure 3.6B). 
 
Confocal microscopy scanning of cell morphology on 3D collagen scaffolds 
Immediately following drug permeability testing, the collagen scaffolds with Caco-2 
monolayers were detached from modified well inserts and scanned by confocal 
microscopy. Confocal scanning demonstrated that on 2D collagen scaffolds a 
polarized cell monolayer formed (Figure 3.8G). On 3D collagen scaffolds cells tended 
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to degrade the structures over time, resulting in heights of 330 µm on average by the 
end of the experiment 20(Figure 3.8A and B) [ ]. Cell differentiation on 3D scaffolds 
varied along the villous length (in the X-Y orientation): cells were more polarized and 
columnar at the top and less differentiated near the villous base (Figure 3.8C, D, E, 
and F). 
 
Figure 3.8 Confocal scanning pictures, cells are stained green (actin) and blue 
(nucleic acid). (A) 3D villi with Caco-2 cells after 3D rendering (1 unit=37.6µm) (B) 
X-Z section picture of single villous (C,D,E,F) Confocal X-Y section picture of single 
villous from top to bottom (G) X-Z section of a Caco-2 monolayer on 2D collagen. 
The scale bars in B, C, D, E, F and G are 43µm. 
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Cell density counts indicated that there was a slightly higher density of cells near the 
top of the villi than at the bottom (Figure 3.9). The actually surface area of 3D 
collagen villi was estimated. Size parameters of villi (average values) were estimated 
from confocal scans. The heights were 330 µm on average. The top and basal areas 
were treated as circles with 32.5 µm radii and 90 µm radii, respectively (Figure 3.10). 
The sealing area was measured as 0.289cm2 and villi density was 25 villi per mm2. 
The actually surface area of 3D collagen was 1.06cm2, which was about 3.7 times 
higher than the surface area of the 2D scaffold (0.289cm2
 
). 
Figure 3.9 Cell density in X-Y section of a 3D collagen villus. Top, middle and 
bottom are related to the Z position of a single villus. Top sections were counted at 
approximately 200-300 µm from the base. Middle sections are approximately 100-200 
µm from the base. Bottom sections are approximately 50-100 µm from the base. 
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Figure 3.10 3D collagen villi surface area estimation 
 
 
Adult mouse and human small intestine paraffin sections were used to investigate in 
vivo small intestinal epithelial differentiation (Figure 3.11). Alkaline Phosphatase, a 
brush border digestive enzyme which is frequently used as an enterocyte 
differentiation marker, was chosen as the target for 
 
immunofluorescence. In the mouse 
section, a uniform Alkaline Phosphatase immunofluorescence intensity was observed 
along the crypt-villus axis (Figure 3.11A). In contrast, in the human section, Alkaline 
Phosphatase immunofluorescence intensity increased along the crypt-villus axis 
(Figure 3.11B). 
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Figure 3.11 Immunofluorescence pictures of mouse (A) and human (B) small 
intestine paraffin sections. Nucleic acid is stained blue, Alkaline Phosphatase is 
stained red.    
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DISCUSSION 
An advantage of soft-hydrogel structures for culturing epithelial cells is that they 
allow for transport away from cells basolaterally, whereas hard or impermeable 
surfaces do not permit transport through the cell monolayer. Here we took advantage 
of the biocompatible hydrogel, collagen, to make villous scaffolds capable of 
supporting human intestinal cell growth in a physically accurate 3D culture. Our 
modified well insert design protected the scaffolds and insured that they were sealed 
from short-circuiting. A disadvantage of collagen is that for more rapidly transported 
drugs, the scaffold becomes the limiting barrier (Figure 3.6). We are investigating 
alternate hydrogels to determine their appropriateness for rapidly absorbed drug 
permeability testing. 
 
In the standard protocol, Caco-2 cells need to be cultured for 21 days before the drug 
permeability test [11]. However, we have found that culturing Caco-2 cells on 
collagen scaffolds for 21 days not only further shortened the height of the villi, but 
more importantly, also resulted in the formation of multiple cell layers due to cell 
penetration and degradation of the collagen, which in our opinion is crucial to avoid in 
in vitro drug permeability tests [20]. Having multiple cell layers on 2D or 3D collagen 
scaffolds makes it difficult to compare results to drug permeability tests performed on 
conventional well inserts in which the test is conducted on a cell monolayer. Hence, in 
this study we had to conduct the permeability test with collagen scaffolds after 
culturing Caco-2 cells for 14 days to avoid multiple cell layers forming. To verify that 
tight junctions were properly formed after 14 days, we compared the permeability 
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coefficients of Antenolol on conventional well inserts between 14 days culture and 21 
days culture. No statistically significant differences were found between the two 
(Figure 3.12). The confocal scanning of Caco-2 cells cultured for 14 days on 2D 
collagen (Figure 3.8G) also suggested that a polarized cell monolayer was formed, 
which is consistent with the high TEER values and low Antenolol permeability 
coefficients of 2D collagen cultures.  
 
The 3D synthetic villi TEER values and permeability coefficients reflected 
mammalian intestinal values more accurately than did those for the 2D surfaces. The 
low TEER value over the 3D collagen synthetic villi matched that reported for a rat 
ileum (Figure 3.5) and human intestinal epithelia [10]. Our results with Antenolol 
suggest that there is a difference between cells growing on 2D and 3D surfaces that 
cannot be explained by the difference in surface area between the two (Figure 3.10). It 
has been shown that tight junctions increase in leakiness from the tip of the villous to 
the crypt in normal juvenile intestines [17]. This property of intestinal villi may help 
explain the permeability difference we found between 3D-grown and 2D-grown 
monolayers when considered with the pathway through which Antenolol is absorbed. 
Slowly absorbing drugs, like Antenolol which rely on the paracellular pathway for 
uptake, may diffuse further along the villi before being absorbed and hence are mostly 
taken up by cells near the crypts rather than on the villous tips [4]. That this absorption 
is faster than it would be in 2D culture is supported by confocal data that indicates 
Caco-2 cells are less differentiated along the lower section of the 3D scaffolds than at 
the tips (Figure 3.8C–F) as well as cell counts that indicated there was a slightly 
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higher density of cells near the top of the villi than at the bottom (Figure 3.9). To 
further prove this point, we investigated in vivo epithelial differentiation of mouse and 
human small intestines (Figure 3.11).  Uneven Alkaline Phosphatase expressions 
along the crypt-villus axis were only found in human small intestine, which suggested 
that Caco-2 cells differentiated in an identical way along the crypt-villus axis when 
comparing to the human while the mouse in vivo model failed to mimic certain human 
epithelial differentiation characteristics at this point. 
 
 
Figure 3.12 Permeability coefficient of Antenolol on Corning 0.4 µm polycarbonate 
cell culture insert with Caco-2 monolayer cultured 14 days (the same data used in 
Fig.2b) and Caco-2 monolayer cultured 21 days (the same data used in Fig. SI-3b). No 
statistically significant differences were found between the two. 
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While it is clear that cell morphology in the 3D collagen system cannot capture all of 
the differences between in vitro systems and actual small intestinal epithelium, this 
study demonstrates the importance of the 3D microenvironment on cell behavior as 
unique cell differentiation was observed only in the 3D model. We believe that our 3D 
culturing method using physically mimetic villous scaffolds is more physiologically 
relevant and therefore more accurate for determining drug permeability coefficients 
than conventional methods. To further explore the 3D in vitro model, alternative 
scaffold materials need to be investigated to overcome the transport barrier problem 
for rapid absorption, which will allow drugs with a wider range of absorption rates to 
be tested in this 3D in vitro model. This culturing system could also be used to 
investigate cell differentiation using established stem cell culturing techniques [18] 
and to begin to understand more completely the role between the physical 
environment and cellular interactions between human epithelia and microorganisms 
living in the GI tract. 
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ABSTRACT 
We investigated the potential of using poly (lactic-co-glycolic acid) (PLGA) as a 
biocompatible material for a 3D in vitro model of human upper gastrointestinal tract. 
PLGA villous scaffolds were obtained by utilizing a replica molding method. Caco-2 
and HT-29 MTX cells were co-cultured on PLGA villous scaffolds to test 
biocompatibility. To make PLGA villous scaffolds permeable, porogen leaching and 
laser ablation methods were investigated, which suggested that porous PLGA villous 
scaffold could be achieved by combining two methods together. Overall, this study 
showed that PLGA is a good candidate material for 3D in vitro model of human upper 
gastrointestinal tract. 
   
INTRODUCTION 
In vitro models of human gastrointestinal tract have played a critical role for in vitro 
drug permeability determination [2]. Recently, new stem cell culture techniques have 
enabled the differentiation of human pluripotent stem cells into functional human 
small intestine epithelia in vitro [15]. Additionally, 3D biocompatible scaffolds with 
physiologically relevant dimensions were made by microfabrication techniques to 
mimic small intestinal villi [16]. These studies not only illustrated a promising way to 
achieve a better in vitro model for drug permeability determination but also suggested 
a possibility to make a functional artificial small intestine for treating intestine-related 
diseases such as short bowel syndrome. 
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In previous studies, by using collagen villous scaffolds, we have demonstrated that a 
3D in vitro model could improve drug permeability testing and present unique cell 
differentiation characteristics along the crypt-villus axis which were identical to 
human small intestine epithelia [20]. However, collagen villous scaffolds lack 
mechanical flexibility and have to preserve its shape in liquid, making it is difficult for 
transportation and surgical use.  Moreover, the permeability of rapidly absorbed drugs 
in collagen scaffolds was not fast enough to enable testing [20].  
 
In this study, we investigated the potential of using poly (lactic-co-glycolic acid) 
(PLGA) to fabricate a 3D in vitro human small intestine model. PLGA, as a 
biocompatible and biodegradable co-polymer material, has been widely used in tissue 
engineering and approved by the Food and Drug Administration for drug delivery [4, 
5, 11]. There are several advantages to use PLGA for making 3D small intestine 
scaffold. First, PLGA has good mechanical properties [7]. It is not difficult to use it 
for fabricating high aspect ratio 3D structures at the micrometer scale. Second, various 
methods have been reported to fabricate a porous PLGA scaffolds including porogen 
leaching [9], gas foaming [10], emulsion freeze drying [18], phase separation [12] and 
3D printing [8]. Third, PLGA has been used as surgical suture material for many years 
and numerous in vivo studies have suggested that PLGA has excellent 
biocompatibility and predictable biodegradability [5, 7, 14, 17, 19]. For surgical 
applications, PLGA has lower chance to induce immunogenicity compared to 
naturally derived polymer such as collagen. Hence, PLGA is an attractive material for 
making human small intestinal villi intended for implantation or for in vitro models 
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that will ultimately have immune components. The goal of this study was to fabricate 
a porous PLGA villous scaffold with controlled pore size that can allow for passage of 
small molecules and larger proteins but still prevent cellular invasion.   
 
MATERIALS AND METHODS 
Fabrication of PLGA villous scaffold 
Polymethylmethacrylate (PMMA) villous template was used to fabricate PLGA 
scaffold. The fabrication of this PMMA template was described in a previous study 
[20].  To make a PLGA scaffold, Polydimethylsiloxane (PDMS, Dow Corning, 
Midland, MI) mixture was poured onto PMMA mold and put into vacuum oven 
forming PDMS villi structure mold first. The PDMS villi structure mold was then 
treated by 0.1% (w/w) hydroxypropyl methylcellulose (HPMC, Sigma, St. Louis, MO) 
solution for 30 min under room temperature to increase the surface hydrophilicity [3]. 
The HMPC solution was then rinsed, and the PDMS mold was quickly put into a Petri 
dish and covered by 3 % agarose solution, which gelled to form an agarose template. 
The PDMS mold was gently pilled off the agarose template and the agarose template 
was air-dried an hour to evaporate water residue inside the template holes. 10% (w/v) 
PLGA (85:15, Durect Corporation, Birmingham, AL) in chloroform solution was 
added to agarose template and put into vacuum oven right away to remove any gas 
inside holes. Then the agarose template with PLGA was left in chemical hood for 3 
hours to evaporate all the chloroform solvent. Due to the flexibility of agarose and 
PLGA, the PLGA villous scaffold can be obtained by gently pilling off the agarose 
template. The whole fabrication process was illustrated in Figure 4.1. 
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Figure 4.1 Fabrication process of the PLGA villous scaffold 
 
Cell culture 
The human colon carcinoma cell line Caco-2 (passage number 16-25, ATCC, 
Manassas, VA) HT29-MTX (passage number 39-49, a kind gift from Professor 
Michael L. Shuler, Cornell University) were used in this study. Both cell lines were 
maintained in Dulbecco’s Modified Eagle’s Media (Mediatech, Manassas, VA), with 
10% FBS (Invitrogen, Carlsbad, CA) and 1X anti-biotic anti-mycotic (Invitrogen). For 
coculture on PLGA scaffolds, PLGA scaffolds were sterilized in 70% ethanol 
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overnight and washed with PBS for 3 days. Caco-2 and HT29-MTX cells were seeded 
on PLGA scaffolds with a 3:1 ratio (Caco-2:HT29-MTX) at 1 × 106
 
 cells/ml seeding 
density. Media was exchanged 1 day after seeding and every 2 days during the 
experiment.    
Fabrication of PLGA villous scaffold using porogen leaching method 
Sucrose fine powder was mixed with ammonium bicarbonate fine powder with 1 to 1 
weight ratio.  The powder mixture was further fined by hand using mortar and pestle 
for 30 min. Then the powder mixture was add to 10% (w/v) PLGA (85:15, Durect 
Corporation) in chloroform and a homogenizer (model µH, Omni International, 
Kennesaw, GA) was used to mix the powder with PLGA-chloroform solution. Right 
after the homogenizer mixing, the solution mixture was added to agarose template and 
put into vacuum oven for removing gas bubbles. Then agarose template with PLGA 
mixture on top was left in chemical hood for 3 hours and then submerged in 45 °C 
water overnight to dissolve all the porogens.   
 
Laser ablation on PLGA scaffold 
Laser ablation was performed at Professor Chris B. Schaffer’s Lab at Cornell 
University using a Femtosecond laser system including a Ti:Sapphire regenerative 
amplifier (Legend 1k USP, Coherent Inc, Santa Clara, CA), a Q-switched laser 
(Evolution 15, Coherent Inc.) and a  Ti:Sapphire oscillator (Kapteyn-Murnane 
Laboratories Inc., Boulder, CO).  Real time image was obtained by using a custom-
designed two-photon excited fluorescence microscope utilizing a modelocked 
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Ti:Sapphire laser (Chameleon, Coherent Inc.). PLGA scaffold was stained by 1:1000 
diluted TO-PRO-3 (Invitrogen) solution overnight to generate enough fluorescence. A 
20X magnification, water-immersion objective (Zeiss, Thornwood, NY) was used 
with the two-photon excited fluorescence microscope 
 
Dye Test 
PLGA villous scaffolds were assembled in custom-made insert kits. Details of the 
insert kit were described in a previous study [20]. NEON blue food dye solution 
(McCormick & Co, Hunt Valley, MD) was added to the apical side of the insert kit. A 
wiper paper was used to detect if any dye was able to pass through PLGA villous 
scaffolds.  
 
Microscopy 
For Scanning electron microscope (SEM), PLGA samples were coated by an Au-Pd 
sputter coater (Denton DESK II, Denton Vacuum, Moorestown, NJ). Leica Stereoscan 
440 Scanning electron microscope (Leica Microsystems, Buffalo Grove, IL) was used 
to exam the sample. For confocal microscope, cell samples were stained by Alexa 
Fluor 488 phalloidin (Invitrogen) and TO-PRO-3 for actin and nucleic acid staining, 
respectively. Leica SP2 confocal microscope (Leica Microsystems, Buffalo Grove, IL) 
was used to scan the sample. 3D rendering images and section pictures were 
assembled with Volocity 5.0 software (Perkin Elmer, Waltham, MA). 
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RESULTS 
PLGA villous scaffold can be made by replica molding method due to its good 
mechanical properties. Agarose gel was chosen as the final template based on two 
reasons. First, the chloroform solvent of PLGA could easily destroy the PMMA 
template. Second, the agarose gel is soft and flexible, which provided a good 
protection of the villous shape when PLGA scaffold was peeled off the agarose 
template. SEM pictures showed that the final PLGA scaffold processed villi array as 
designed that each villus has full high aspect ratio shape and smooth curvature (Figure 
4.2). 
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Figure 4.2 SEM pictures of the PLGA villous scaffold with (A) low magnification 
and (B) high magnification. 
 
Caco-2 and HT-29 MTX were co-cultured on the PLGA villous scaffold to mimic the 
small intestinal enterocytes and goblet cells respectively. PLGA itself could support 
Caco-2 and HT-29 MTX proliferation along the villus without any collagen or 
Matrigel coating (Figure 4.3), which proved its excellent biocompatibility 
characteristic. However, even with collagen coating, cells on PLGA scaffolds failed to 
sustain proliferation and differentiation over a certain culture time, which suggested 
that there were limitations to either nutrient transport to or waste transport away from 
the cells as they grew. We hypothesized that basolateral feeding may allow longer 
culture times. 
 
Figure 4.3 Confocal pictures of Caco-2 and HT-29 MTX cocultured on the PLGA 
villous scaffold. (A) X-Y section picture (B) 3D rendering picture of a single villus. 
Cells are stained green (actin) and blue (nucleic acid). 
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A porogen leaching method was utilized to make porous PLGA villous scaffold. By 
controlling porogen particle size, less than 10 µm holes were obtained on PLGA 
scaffold surface (Figure 4.4). It is need to note that the PLGA scaffold lost some 
mechanical strength and became fragile after being made using porogen leaching 
method. But overall it is still strong enough that PLGA villi do not need to be 
preserved in liquid phase. 
 
Figure 4.4 SEM pictures of the PLGA villous scaffold made by porogen leaching 
method with (A) low magnification and (B) high magnification. 
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A femtosecond laser ablation method was also tested on PLGA scaffolds since it has 
been used to successfully fabricate high aspect ratio microcapillaries on PDMS device 
[6]. The primary result suggested that the diameter of the hole on PLGA surface can 
be controlled within 10µm, which is small enough to block epithelial cells. Hence, it is 
possible to use femtosecond laser ablation to create micro sized channels on PLGA 
villous scaffold, which makes it similar as the commercially available membranes 
made by track etching technique [1]. Dye test results also suggested that PLGA villous 
scaffold treated by the laser ablation became permeable to dye solution, which proved 
the functionality of holes (Figure 4.6).  
  
Figure 4.5 SEM picture of the PLGA scaffold with a single hole drilled by laser 
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Figure 4.6 Dye test results of a PLGA villous scaffold without laser drilling (left) and 
a PLGA villous scaffold with laser drilling (right)  
 
DISCUSSION 
The advantage of PLGA is that, due to its good mechanical properties, a PLGA villous 
scaffold can be made just using replica molding method, which is much easier when 
compared to the method used for making collagen villous scaffolds [16]. However, 
cell culture on PLGA needs to be improved to show that fully differentiated epithelial 
cells can be achieved on PLGA villous scaffold. Hence, having a porous villous 
scaffold is crucial that it not only provides the ability to feed epithelial cells from 
basolateral side which is physiological relevant comparing to in vivo epithelial cell 
feeding but also makes PLGA scaffold useful for in vitro drug permeability 
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determination [13]. Porogen leaching and femtosecond laser ablation results suggested 
two different ways to make PLGA porous. The challenging part is to make porous 
PLGA scaffold when still preserving the villous structure. Combining two methods 
together in the future research that using the laser ablation to interconnect holes 
created by porogens could possibly obtains an ideal porous PLGA villous scaffold. 
Overall, this primary study suggested that PLGA is a good candidate material for 
making 3D villous scaffold. 
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The challenges of improving current human small intestine in vitro models mainly 
come from two aspects. The first challenge is to find a suitable material for fabricating 
3D scaffolds. The material has to be capable of supporting epithelial cells forming a 
differentiated monolayer over long term culture, and the material has to be permeable 
enough so that it does not present a significant barrier for nutrient and drug transport. 
The fast development of biomaterials, especially various hydrogel techniques over last 
two decades, has already had profound impact on tissue engineering [2]. Apart from 
materials we described in previous chapters, we also tested other hydrogels. For 
example, we started with a simple idea involving the use of a Matrigel-coated agarose 
hydrogel for epithelial cell culture. We found that since Matrigel did not immobilize 
effectively onto the agarose surface, it could not actually promote epithelial cell 
attachment and proliferation. Subsequently, we used a chemical modification method 
to covalently bind RGD (Arg-Gly-Asp) peptides to PEGDA (Poly (ethylene glycol) 
diacrylate) hydrogels [3], and we achieved some success in promoting cell attachment 
and proliferation. However, we discovered that there was a limit to the maximum 
concentration of RGD which could be bound to PEGDA hydrogels, making this 
method inadequate for actually supporting Caco-2 cell proliferation and differentiation 
into a functional monolayer. Furthermore, we tested the idea of mixing PEGDA with 
collagen. Unfortunately, it was very difficult to verify that collagen and PEGDA were 
well mixed during the photopolymerization. Hence, finding a suitable material will 
always be the main challenge of this project, especially with the consideration that the 
materials also need to be capable of being made into the 3D villous shape.  
 
100 
 
The second challenge is to establish new epithelial cell lines with more 
physiologically relevant characteristics for the in vitro model. The Caco-2 cell line has 
been used since the very first small intestine in vitro model. The co-culture of Caco-2 
and HT29-MTX further improved physiological relevance, although the other two 
epithelial cell types were still missing.  Since both Caco-2 and HT29-MTX were 
isolated as colon carcinoma cell lines, to some extent, they still possess different 
characteristics when compared to normal human small intestine epithelial cells [7]. 
Recently, emerging stem cell culture techniques have suggested the possibility of 
differentiating human stem cells into the intestinal tissue with all four small intestine 
epithelial cell types in vitro [6]. Utilizing the advancing stem cell isolation and culture 
techniques could greatly improve the conventional in vitro model. 
 
Since this 3D small intestine in vitro model was developed as a research tool, it can be 
applied to following future research directions. The first direction is to continue 
exploring the potential of using a 3D model for improving drug permeability 
correlations, especially if a better material can be found to overcome the transportation 
barrier problem. The second direction is to combine the stem cell techniques with the 
3D scaffold in order to fabricate an artificial human small intestine for treating short 
bowel syndrome. Currently there is no effective way for treating short bowel 
syndrome. Seeding stem cells on the 3D scaffold and thus forming a functional 
artificial small intestine in vitro for subsequent implantation may provide a cure for 
this fatal disease. The third direction is to use this 3D model for investigating the 
interactions between commensal bacteria and small intestine epithelia. There is a large 
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population of commensal bacteria located in human intestine [4]. Understanding 
communication and interactions between commensal bacteria and small intestinal 
epithelia may help in the study of the causes of intestine-related diseases [1, 5]. 
Overall, the 3D small intestine in vitro model can be a powerful tool for intestine-
related research.   
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